Insider Transactions in Q1 2023 at Hims & Hers Health, Inc. (HIMS)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 20
2023
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
9,333
-1.92%
|
$83,997
$9.54 P/Share
|
|
Mar 17
2023
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
13,745
-7.56%
|
$123,705
$9.79 P/Share
|
|
Mar 17
2023
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,720
-6.98%
|
$141,480
$9.9 P/Share
|
|
Mar 17
2023
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
6,170
-28.71%
|
$55,530
$9.79 P/Share
|
|
Mar 17
2023
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,176
-2.05%
|
$91,584
$9.79 P/Share
|
|
Mar 16
2023
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
11,943
-0.79%
|
$107,487
$9.94 P/Share
|
|
Mar 15
2023
|
Irene Becklund PAO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,595
-20.65%
|
$50,355
$9.01 P/Share
|
|
Mar 15
2023
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,847
+36.91%
|
-
|
|
Mar 15
2023
|
Kristen Green Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,449
+11.11%
|
-
|
|
Mar 15
2023
|
David B Wells Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,043
+2.79%
|
-
|
|
Mar 15
2023
|
Oluyemi Okupe Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
102,347
-47.15%
|
$921,123
$9.01 P/Share
|
|
Mar 15
2023
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
209,580
+49.12%
|
-
|
|
Mar 15
2023
|
Garcia Andrea G Perez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,122
+33.33%
|
-
|
|
Mar 15
2023
|
Soleil Boughton Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,261
-3.84%
|
$65,349
$9.01 P/Share
|
|
Mar 15
2023
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,006
+10.0%
|
-
|
|
Mar 15
2023
|
Melissa Baird Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,828
-1.71%
|
$79,452
$9.01 P/Share
|
|
Mar 15
2023
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,280
+6.57%
|
-
|
|
Mar 15
2023
|
Jules A. Maltz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,449
+10.51%
|
-
|
|
Mar 15
2023
|
Ambar Bhattacharyya Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,122
+20.0%
|
-
|
|
Mar 15
2023
|
Delos M. Cosgrove Director |
BUY
Exercise of conversion of derivative security
|
Direct |
565
+7.14%
|
-
|
|
Mar 15
2023
|
Michael Chi Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,726
-11.6%
|
$132,534
$9.01 P/Share
|
|
Mar 15
2023
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,853
+24.35%
|
-
|
|
Mar 15
2023
|
Patrick Harrison Carroll Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,286
+15.58%
|
-
|
|
Mar 15
2023
|
Alex Bard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,449
+11.11%
|
-
|
|
Mar 15
2023
|
Lynne Chou O'Keefe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,043
+50.0%
|
-
|
|
Mar 15
2023
|
Andrew Dudum Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
41,122
-9.63%
|
$370,098
$9.01 P/Share
|
|
Mar 15
2023
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
76,454
+15.18%
|
-
|
|
Mar 14
2023
|
Jules A. Maltz Director |
BUY
Other acquisition or disposition
|
Indirect |
2,449
+50.0%
|
-
|
|
Mar 14
2023
|
Jules A. Maltz Director |
SELL
Other acquisition or disposition
|
Direct |
2,449
-11.74%
|
-
|
|
Mar 14
2023
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,000
-1.18%
|
$18,000
$9.09 P/Share
|
|
Mar 08
2023
|
David B Wells Director |
SELL
Open market or private sale
|
Direct |
100,000
-22.71%
|
$900,000
$9.77 P/Share
|
|
Mar 03
2023
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
566
-4.79%
|
$5,660
$10.46 P/Share
|
|
Mar 03
2023
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
566
+4.57%
|
$566
$1.75 P/Share
|
|
Mar 03
2023
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,249
-0.36%
|
$13,739
$11.96 P/Share
|
|
Mar 03
2023
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,249
+0.35%
|
$2,498
$2.43 P/Share
|
|
Mar 02
2023
|
Jules A. Maltz Director |
SELL
Open market or private sale
|
Indirect |
36,820
-25.04%
|
$368,200
$10.1 P/Share
|
|
Mar 02
2023
|
Jules A. Maltz Director |
BUY
Other acquisition or disposition
|
Indirect |
728,224
+45.05%
|
-
|
|
Mar 02
2023
|
Jules A. Maltz Director |
SELL
Other acquisition or disposition
|
Indirect |
5,599,601
-54.68%
|
-
|
|
Mar 02
2023
|
Institutional Venture Management Xv, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
5,062,458
-43.35%
|
-
|
|
Mar 02
2023
|
Institutional Venture Management Xv, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
95,680
+50.0%
|
-
|
|
Mar 02
2023
|
Institutional Venture Management Xv, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
537,143
-100.0%
|
-
|
|
Mar 02
2023
|
Institutional Venture Management Xv, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
537,143
+50.0%
|
-
|
|
Mar 02
2023
|
Alex Bard Director |
SELL
Open market or private sale
|
Indirect |
2,319,109
-23.43%
|
$23,191,090
$10.78 P/Share
|
|
Mar 01
2023
|
Alex Bard Director |
SELL
Open market or private sale
|
Indirect |
500,000
-4.81%
|
$5,500,000
$11.55 P/Share
|
|
Mar 01
2023
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,857
-16.86%
|
$229,427
$11.7 P/Share
|
|
Mar 01
2023
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,633
-9.46%
|
$402,963
$11.95 P/Share
|
|
Mar 01
2023
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,633
+8.64%
|
$73,266
$2.43 P/Share
|
|
Feb 15
2023
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
9,625
-46.13%
|
$96,250
$10.0 P/Share
|
|
Feb 15
2023
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,625
+31.57%
|
$9,625
$1.75 P/Share
|
|
Feb 15
2023
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
65,000
-27.65%
|
$650,000
$10.01 P/Share
|